 Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores
Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26
GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26 The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore
The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores
Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores
Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores 
              The Initial Public Offering (IPO) of Claris Lifesciences Limited will open for subscription by investors on November 24, 2010. The company is coming out with public issue of equity shares of Rs.10 each for cash aggregating to Rs.300 crores.
The 100% book building issue is priced in a price band of Rs.278 to Rs.293. The Minimum Order Quantity is 22 Equity Shares and in multiples of 22 Equity Shares. The Maximum Subscription Amount for Retail Investor is Rs.200000.
The Rating Agency Fitch Ratings India Private Limited has assigned IPO Grading of IPO Grade 3.
Enam Securities Private Limited, Edelweiss Capital Limited, JM Financial Consultants Private Limited and ICICI Securities Limited are the Book Running Lead Managers to the IPO. Edelweiss Securities Limited and JM Financial Services Private Limited are the Syndicate Members to the IPO.
Link Intime India Private Limited is the registrar to the company.
The IPO closes for subscription on November 26, 2010.